Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Merck
Express Scripts
Mallinckrodt
McKinsey
Harvard Business School
Colorcon

Last Updated: November 14, 2019

DrugPatentWatch Database Preview

Litigation Details for SUPERNUS PHARMACEUTICALS, INC. v. PAR PHARMACEUTICAL COMPANIES, INC. (D.N.J. 2015)

See Plans and Pricing

« Back to Dashboard

SUPERNUS PHARMACEUTICALS, INC. v. PAR PHARMACEUTICAL COMPANIES, INC. (D.N.J. 2015)

Docket   Start Trial Date Filed 2015-01-16
Court District Court, D. New Jersey Date Terminated 2015-10-16
Cause 35:271 Patent Infringement Assigned To Susan Davis Wigenton
Jury Demand None Referred To Magistrate Judge Leda D. Wettr
Parties PAR PHARMACEUTICAL COMPANIES, INC.; PAR PHARMACEUTICAL, INC.; SUPERNUS PHARMACEUTICALS, INC.
Patents 4,513,006; 4,727,064; 4,757,128; 4,938,763; 5,030,447; 5,180,589; 5,378,475; 5,998,380; 6,248,363; 6,503,884; 6,514,531; 7,763,635; 8,298,576; 8,298,580; 8,663,683; 8,877,248; 8,889,191; 8,992,989
Attorneys ARNOLD B. CALMANN; CHARLES MICHAEL LIZZA; GERI L. ALBIN; JEFFREY S. SOOS; RICHARD FRANK KURZ; SARAH ANN SULLIVAN; WILLIAM C. BATON
Link to Docket External link to docket
Small Molecule Drugs cited in SUPERNUS PHARMACEUTICALS, INC. v. PAR PHARMACEUTICAL COMPANIES, INC.
The small molecule drugs covered by the patents cited in this case are   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial , and   Start Trial .
Biologic Drugs cited in SUPERNUS PHARMACEUTICALS, INC. v. PAR PHARMACEUTICAL COMPANIES, INC.
The biologic drugs covered by the patents cited in this case are   Start Trial and   Start Trial .

Details for SUPERNUS PHARMACEUTICALS, INC. v. PAR PHARMACEUTICAL COMPANIES, INC. (D.N.J. 2015)

Date Filed Document No. Description Snippet Link To Document
2015-01-16 1 , to release the active ingredient 4,513,006 A 4/1985 Maryanoff et a!. …ed., 2538-2447 (2006); see also, U.S. Pat. No. 4,513,006. inunediate release (IR) component… A 2/1984 Urquhart et a!. 4,513,006 A 4/1985 Maryanoff et a!. …ed., 2538-2447 (2006); see also, U.S. Pat. No. 4,513,006. dient, wherein the active ingredient…PageID: 2 ’576 patent”), 8,298,580 (“the ’580 patent”), 8,663,683 (“the ’683 patent”), and 8,877,248 External link to document
2015-03-12 17 States Patent Nos. 8,298,576 (“the ’576 patent”), 8, 298,580 (“the ’580 patent”), 8,663,683…United States Patent Nos. 8,298,576 (the “’576 patent”), 8, 298,580 (the “’580 patent”), 8,663,683 (…seq., that U.S. Patent Nos. 8,298,576 (the “’576 patent”); 8,298,580 (the “’580 patent”); 8,663,683 (… (Declaratory Judgment Regarding U.S. Patent No. 8,298,576) 12. Counterclaim Plaintiffs…Defendants hereby certifies that United States Patent Nos. 8,298,576, 8, 298,580, 8,663,683, 8,877,248, and 8,889,191 External link to document
2015-10-16 67 for infringement of United States Patent Nos. 8298,576, 8,298,580, 8,663.683, 8.877,248, 8,889.191,…PERMANENT INJUNCTION This action for patent infringement having been brought by Plaintiff Supernus…and 8.992,989 (collectiveiy, the “Litigated Patents”); Par and Supernus have agreed…product, would infringe each of the Litigated Patents in the absence of a license; and Case 2:15-cv-00326… stated and limited herein, that the Litigated Patents, and all the claims contained therein, are External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Baxter
Moodys
Johnson and Johnson
Dow
Colorcon
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.